South West Yorkshire Partnership NHS Foundation Trust 2024

20 August 2025

BY EMAIL

Wendy Micklewright

Information Governance

South West Yorkshire Partnership NHS Foundation Trust

Fieldhead

Ouchthorpe Lane

Wakefield

WF1 3SP

Ref: FOI 5197

E-mail: foi@swyt.nhs.uk

Dear Wendy

Thank you for your recent email which we received on 16 May 2025, and in which you requested information under the Freedom of Information Act.

We have requested the information from the appropriate information holders within the Trust and received the following answers to your questions:

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: -

1.Please supply patient’s information ECT leaflet

Please see attached:

2.Please supply patient ECT consent form

Please see attached:

3.Please supply any ECT reports/investigations

4.How many ECT in 2024?

5.What proportion of patients were men/women?

85% Female

15 % Male

6.How old were they?

Between 27 – 83 years old.

7.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

8.How many people covered by the equality act - specific protected characteristics - excluding age + gender - received ECT?

<5, an exemption is being applied to the exact number under section 40(2) of the Act as its disclosure would increase the risk of identification. Therefore, it constitutes personal data, and the Trust would be in breach of the first and second principles for processing under the UK General Data Protection Regulation if it released this information into the public domain

9.How many people were offered talking therapy prior to ECT?

All.

10.How many were receiving ECT for the first time?

11.How many patients consented to ECT?

11, the remaining patients received treatment in accordance with the Mental Capacity Act (MCA) or Mental Health Act (MHA).

12.How many ECT complaints were investigated outside the NHS?

None.

13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?

<5, Due to unknown medical causes. An exemption is being applied to the exact number under section 40(2) of the Act as its disclosure would increase the risk of identification. Therefore, it constitutes personal data, and the Trust would be in breach of the first and second principles for processing under the UK General Data Protection Regulation if it released this information into the public domain.

14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?

15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?

16.How many patients have suffered complications during and after ECT and what were those complications?

17.Have there been any formal complaints from patients/relatives about ECT?

No.

18.If so, what was their concerns?

Not applicable.

19.How many patients report memory loss/loss of cognitive function?

20.What tests are used to assess memory loss/loss of cognitive function?

6 cit and ACE 111.

21.Have MRI or CT scans been used before and after ECT?

<5 occasion

An exemption is being applied to the exact number under section 40(2) of the Act as its disclosure would increase the risk of identification. Therefore, it constitutes personal data, and the Trust would be in breach of the first and second principles for processing under the UK General Data Protection Regulation if it released this information into the public domain.

22.If so, what was the conclusion?

Prescribe ECT.

23.How does the Trust plan to prevent ECT in the future?

No plans to stop use of ECT, this is something the service offers, and it is part of the treatment pathway and in line with National Institute for Health and Care Excellence

(NICE) Guidance.

Please provide restraints information under the FOI act to the following questions: -

Notes:

Percentages may not total 100% due to records which do not have data recorded.

1.Please supply any Restraints/investigations

There were 0 investigations into restraints for 2024.

2.How many RESTRAINTS in 2024?

2402

3.What proportion of patients were men/women?

Please see below:

Female	36%
Male	63%

4.How old were they?

Please see below:

Under 18	17
18 to 24 years	623
25 to 34 years	410
35 to 44 years	286
45 to 54 years	339
55 to 64 years	254
65 to 74 years	110
75 years and over	352
Not recorded	11

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

Please see below:

BAME

20%

6. How many people covered by the equality act - specific protected characteristics - excluding age + gender - were restrained?

The trust is unable to provide a response for this question as data is not recorded in extractable format.

7.How many RESTRAINTS were investigated outside the NHS?

This information is not available to the Trust.

8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

An exemption is being applied to this part of the request under section 12 of the Act. The requested information is not held centrally on the Trust's information systems and identifying, locating, retrieving, and collating it would require manual scrutiny of all relevant records, which will exceed the timescale for compliance. Questions which refer to deaths and types of events within a period time before death, Patient Safety Support Team (PSST) do not have this level of information from deaths recorded.

9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?

11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?

There have been no patients that have suffered complications during or after restraints.

12.Have there been any formal complaints from patients/relatives about RESTRAINTS?

No.

13.If so, what was their concerns?

Not applicable.

14.Are counts of forced injections available? if so how many people were forcible injected?

Yes - 88.

15.How does the Trust plan to reduce restraints in the future?

The Trust has a reducing restrictive physical intervention statement and plan to reduce the number of restraints across the Trust.

16.How many of these restraints were face down restraints?

165.

Please provide SECLUSION information under the FOI act to the following questions: -

Notes:

Percentages may not total 100% due to records which do not have data recorded.
Below information is based on the information on the person if they were restrained due to the way data is collected on the risk management system.

1.Please supply any SECLUSION reports/investigations

Following every episode of seclusion, a debrief takes place as part of a learning response. No reports or investigations have been completed during 2024.

2.How many SECLUSIONS in 2024?

664

3.What proportion of patients were men/women?

Please see below:

Female	21%
Male	48%

4.How old were they?

Please see below:

Under 18	6
18 to 24 years	80
25 to 34 years	110
35 to 44 years	108
45 to 54 years	90
55 to 64 years	42
65 to 74 years	9
75 years and over	14
Not recorded	205

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

Please see below:

BAME

20%

6. How many people covered by the equality act - specific protected characteristics - excluding age + gender - were secluded?

The trust is unable to provide a response for this question as data is not recorded in extractable format.

7.How many SECLUSIONS were investigated outside the NHS?

This information is not available to the trust.

8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?

11.How many patients have suffered complications during and after SECLUSION and what were those complications?

There have been no patients that have suffered complications during or after seclusion.

12.Have there been any formal complaints from patients/relatives about SECLUSION?

Seclusion is not included as a specific category within the KO41 data collection that all NHS Trusts provide annually to NHS Digital. However, having completed a key word search on the description of complaint field within Datix, I can advise that there has been >5 complaints with the key word ‘seclusion’ in 2024.

13.If so, what was their concerns?

Please see above response to question 12.

14.How does the Trust plan to reduce SECLUSIONS in the future?

The trust has a reducing restrictive physical intervention statement and plan to reduce the number of seclusions across the trust. Within the annual plan there is an identified quality improvement plan for seclusion reporting.

Please provide MEDICATION ERRORS information under the FOI act to the following questions: -

Notes:

Percentages may not total 100% due to records which do not have data recorded.
One incident may have a number of patients affected. Where data is requested for demographic data, this is provided for all the patients affected where recorded

1.Please supply any MEDICATION ERRORS reports/investigations

There have been <5. An exemption is being applied to the exact number under section 40(2) of the Act as its disclosure would increase the risk of identification. Therefore, it constitutes personal data, and the Trust would be in breach of the first and second principles for processing under the UK General Data Protection Regulation if it released this information into the public domain.

2.How many MEDICATION ERRORS in 2024?

1001.

3.What proportion of patients were men/women?

Please see below:

Female	37%
Male	48%

4.How old were they?

Please see below:

Under 18	10
18 to 24 years	25
25 to 34 years	55
35 to 44 years	129
45 to 54 years	89
55 to 64 years	75
65 to 74 years	53
75 years and over	66
Not recorded on contact records	540

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

Please see below:

BAME

13%

Note, this is an approximate figure as there are multiple records where this is not recorded.

6.How many people covered by the equality act - specific protected characteristics - excluding age + gender - endured medication errors?

The trust is unable to provide a response for this question as data is not recorded in extractable format.

7.How many MEDICATION ERRORS were investigated outside the NHS?

None.

8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

<5. An exemption is being applied to the exact number under section 40(2) of the Act as its disclosure would increase the risk of identification. Therefore, it constitutes personal data, and the Trust would be in breach of the first and second principles for processing under the UK General Data Protection Regulation if it released this information into the public domain.

9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?

11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?

12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?

Medication errors are not included as a specific category within the KO41 data collection. However, Prescribing is an overarching category and there is a sub-category of Prescribing error, there are <5 complaints recorded under this category/sub-category.

13.If so, what was their concerns?

Please see above response to question 12.

14.How does the Trust plan to prevent MEDICATION ERRORS in the future?

The Trust has an improvement plan in place and that is overseen by the Safe Medicines Practice Group, Drug and Therapeutics committee and Patient Safety Committee

I hope that this information is useful and helps to fulfil your enquiry under the Freedom of Information Act. If you are not happy with the information supplied with your response or wish to make a complaint, please email foi@swyt.nhs.uk. You also have the right to complain to the Information Commissioner's Office. Details can be found on: https://ico.org.uk/.

Yours sincerely,

Julie Hall

Deputy Director of CPH Integration